Period Ending | Jun 29, 2012 | Mar 30, 2012 |
---|
Total Revenue
|
197,148
|
183,715
| Cost of Revenue | 2,926 | 2,734 | |
Gross Profit
|
194,222
|
180,981
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
|
Selling General and Administrative | 104,069 | 101,484 |
|
Non Recurring |
-
|
-
|
|
Others | 6,475 | 6,120 |
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
83,678
|
73,377
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (6,944) | (2,236) |
|
Earnings Before Interest And Taxes | 76,734 | 71,141 |
|
Interest Expense |
-
|
-
|
|
Income Before Tax | 76,734 | 71,141 |
|
Income Tax Expense | 23,569 | 22,970 |
|
Minority Interest | (146) | (60) |
|
|
|
Net Income From Continuing Ops | 53,019 | 48,111 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
53,019
|
48,111
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
53,019
|
48,111
|
|